It is used both to treat tumours and to help clinicians determine whether they are cancerous, as well as their grade and ...

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...

Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC)—and after decades with few major advances, newly presented data may signal a turning point in how the disease is treated.

Neoadjuvant sacituzumab govitecan plus pembrolizumab achieved a 39% clinical complete response requiring concordant radiographic negativity and pathologic clearance ...

Phase II study tested combination of sacituzumab govitecan plus pembrolizumab ...

To further complicate clinicians’ treatment decisions, Padcev-Keytruda has become the new standard of care in first-line metastatic bladder cancer, raising the possibility that some physicians might ...

Cancer patients on the Isle of Wight are benefiting from faster treatment and shorter hospital stays. Improvements at St Mary’s Hospital mean patients who previously needed overnight care can now ...

Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

Limb-lengthening can add inches to a person’s stature. But its risks have made it controversial. Credit... Supported by By Isabella Kwai Photographs by Matthew Leifheit Isabella Kwai spoke to ...

CORTINA D'AMPEZZO, Italy -- Lindsey Vonn had a "successful" third surgery on her broken left leg following her downhill crash at the Olympics, the American skier said Wednesday. Vonn posted an update ...